BLACKROCK SCI & TECH TRM TR (BSTZ) Fundamental Analysis & Valuation

NYSE:BSTZ • US09260K1016

Current stock price

26.97 USD
+1 (+3.85%)
Last:

This BSTZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BSTZ Profitability Analysis

1.1 Basic Checks

  • In the past year BSTZ was profitable.
  • In the past year BSTZ had a positive cash flow from operations.
  • Of the past 5 years BSTZ 4 years were profitable.
  • Each year in the past 5 years BSTZ had a positive operating cash flow.
BSTZ Yearly Net Income VS EBIT VS OCF VS FCFBSTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA 17.97%
ROE 18.35%
ROIC 11.84%
ROA(3y)17.05%
ROA(5y)-5.44%
ROE(3y)17.36%
ROE(5y)-5.48%
ROIC(3y)N/A
ROIC(5y)N/A
BSTZ Yearly ROA, ROE, ROICBSTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

1.3 Margins

  • In the last couple of years the Profit Margin of BSTZ has declined.
  • BSTZ's Operating Margin has been stable in the last couple of years.
  • BSTZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 92.53%
PM (TTM) 112.1%
GM 92.73%
OM growth 3YN/A
OM growth 5Y0.52%
PM growth 3YN/A
PM growth 5Y-27.07%
GM growth 3YN/A
GM growth 5Y0.49%
BSTZ Yearly Profit, Operating, Gross MarginsBSTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BSTZ Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BSTZ has less shares outstanding
  • BSTZ has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BSTZ is higher compared to a year ago.
BSTZ Yearly Shares OutstandingBSTZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BSTZ Yearly Total Debt VS Total AssetsBSTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • BSTZ has an Altman-Z score of 31.01. This indicates that BSTZ is financially healthy and has little risk of bankruptcy at the moment.
  • The Debt to FCF ratio of BSTZ is 0.07, which is an excellent value as it means it would take BSTZ, only 0.07 years of fcf income to pay off all of its debts.
  • BSTZ has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • Although BSTZ's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.07
Altman-Z 31.01
ROIC/WACCN/A
WACCN/A
BSTZ Yearly LT Debt VS Equity VS FCFBSTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

2.3 Liquidity

  • BSTZ has a Current Ratio of 0.09. This is a bad value and indicates that BSTZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.09 indicates that BSTZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
BSTZ Yearly Current Assets VS Current LiabilitesBSTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BSTZ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.95% over the past year.
  • Measured over the past years, BSTZ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.81% on average per year.
  • The Revenue has grown by 39.80% in the past year. This is a very strong growth!
  • BSTZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.50% yearly.
EPS 1Y (TTM)19.95%
EPS 3YN/A
EPS 5Y-24.81%
EPS Q2Q%146.75%
Revenue 1Y (TTM)39.8%
Revenue growth 3Y141.3%
Revenue growth 5Y0.5%
Sales Q2Q%28.46%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BSTZ Yearly Revenue VS EstimatesBSTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

More info and screens

Find the best growth stocksShow best growing peers

2

4. BSTZ Valuation Analysis

4.1 Price/Earnings Ratio

  • BSTZ is valuated cheaply with a Price/Earnings ratio of 5.90.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, BSTZ is valued rather cheaply.
Industry RankSector Rank
PE 5.9
Fwd PE N/A
BSTZ Price Earnings VS Forward Price EarningsBSTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.97
EV/EBITDA N/A
BSTZ Per share dataBSTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. BSTZ Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.35%, BSTZ is a good candidate for dividend investing.
  • Compared to an average S&P500 Dividend Yield of 1.80, BSTZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.35%

5.2 History

  • BSTZ has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of BSTZ decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
BSTZ Yearly Dividends per shareBSTZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • BSTZ pays out 60.95% of its income as dividend. This is not a sustainable payout ratio.
DP60.95%
EPS Next 2YN/A
EPS Next 3YN/A
BSTZ Yearly Income VS Free CF VS DividendBSTZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B
BSTZ Dividend Payout.BSTZ Dividend Payout, showing the Payout Ratio.BSTZ Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BSTZ Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK SCI & TECH TRM TR

NYSE:BSTZ (5/1/2026, 8:12:47 PM)

26.97

+1 (+3.85%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners30.99%
Inst Owner Change0.36%
Ins Owners0.23%
Ins Owner Change17.04%
Market Cap1.85B
Revenue(TTM)281.00M
Net Income(TTM)315.00M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 8.35%
Yearly Dividend2.72
Dividend Growth(5Y)N/A
DP60.95%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.9
Fwd PE N/A
P/S 6.6
P/FCF 6.97
P/OCF 6.97
P/B 1.08
P/tB 1.08
EV/EBITDA N/A
EPS(TTM)4.57
EY16.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.87
FCFY14.35%
OCF(TTM)3.87
OCFY14.35%
SpS4.09
BVpS24.98
TBVpS24.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number50.6792 (87.91%)
Profitability
Industry RankSector Rank
ROA 17.97%
ROE 18.35%
ROCE 14.99%
ROIC 11.84%
ROICexc 11.84%
ROICexgc 11.84%
OM 92.53%
PM (TTM) 112.1%
GM 92.73%
FCFM 94.66%
ROA(3y)17.05%
ROA(5y)-5.44%
ROE(3y)17.36%
ROE(5y)-5.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y13.19%
ROICexc growth 3YN/A
ROICexc growth 5Y13.33%
OM growth 3YN/A
OM growth 5Y0.52%
PM growth 3YN/A
PM growth 5Y-27.07%
GM growth 3YN/A
GM growth 5Y0.49%
F-Score7
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.07
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 84.44%
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 31.01
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)76.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.95%
EPS 3YN/A
EPS 5Y-24.81%
EPS Q2Q%146.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)39.8%
Revenue growth 3Y141.3%
Revenue growth 5Y0.5%
Sales Q2Q%28.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.89%
EBIT growth 3YN/A
EBIT growth 5Y1.02%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.66%
FCF growth 3Y13.11%
FCF growth 5Y19.93%
OCF growth 1Y14.66%
OCF growth 3Y13.11%
OCF growth 5Y19.93%

BLACKROCK SCI & TECH TRM TR / BSTZ Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLACKROCK SCI & TECH TRM TR (BSTZ) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BSTZ.


What is the valuation status of BLACKROCK SCI & TECH TRM TR (BSTZ) stock?

ChartMill assigns a valuation rating of 2 / 10 to BLACKROCK SCI & TECH TRM TR (BSTZ). This can be considered as Overvalued.


How profitable is BLACKROCK SCI & TECH TRM TR (BSTZ) stock?

BLACKROCK SCI & TECH TRM TR (BSTZ) has a profitability rating of 2 / 10.


Can you provide the financial health for BSTZ stock?

The financial health rating of BLACKROCK SCI & TECH TRM TR (BSTZ) is 3 / 10.